1 |
Abbady AQ, Bronner C, Bathami K, et al (2005). TCR pathway involves ICBP90 gene down-regulation via E2F binding sites. Biochem Pharmacol, 70, 570-9.
DOI
|
2 |
Achour M, Mousli M, Alhosin M, et al (2013). Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1. Biochem Biophys Res Commun, 430, 208-12.
DOI
|
3 |
Alhosin M, Sharif T, Mousli M, et al (2011). Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res, 30, 41.
DOI
|
4 |
Arima Y, Hirota T, Bronner C, et al (2004). Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes to Cells, 9, 131-42.
DOI
|
5 |
Dandache I, et al (2012). Anti-cancer properties of cranberry juice in human colon cancer: Characterization of the cellular and molecular mechanisms. Fundament Clin Pharmacol, 26, 40.
|
6 |
Fang L, Shanqu L, Ping G, et al (2012). Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo. Cancer Chemotherapy Pharmacol, 69, 1079-87.
DOI
|
7 |
Geng Y, Gao Y, Ju H, et al (2012). Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients. Cancer Science, 104, 194-9.
|
8 |
Jenkins Y, Markovtsov V, Lang W, et al (2005). Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Molecular Biology of the Cell, 16, 5621-9.
DOI
|
9 |
Mousli M, Hopfner R, Abbady AQ, et al (2013). ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br J Cancer, 89, 120-7.
|
10 |
Tien AL, Senbanerjee S, Kulkarni A, et al (2011). UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis. Biochemical J, 435, 175-85.
DOI
|
11 |
Wang F, Yang YZ, Shi CZ, et al (2012). UHRF1 promotes cell growth and metastasis through repression of p16 ink4a in colorectal cancer. Ann Surgical Oncol, 19, 2753-62.
DOI
|
12 |
Yang G.L, Zhang LH, Bo JJ, et al (2012). UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer. Medical Oncol, 29, 842-7.
DOI
|